全外显子测序揭示台湾结直肠癌家族高风险及早发性相关胚系变异
该研究对600例台湾结直肠癌患者行全外显子测序,按ACMG指南评估变异致病性,并与1492例对照比较。发现5.2%患者携带遗传性癌症基因致病性变异,早发性病例中达8.2%,并识别CCDC18、CEP135等新候选基因及POLD1新发终止变异。
要点
- 5.2%台湾结直肠癌患者携带遗传性癌症基因致病性变异,早发性病例中为8.2%。
- 发现CCDC18、CEP135等新候选基因,41个候选致病性变异与家族及早发性结直肠癌相关。
- 在26岁患者中检出POLD1新发终止变异p.Y594X,提示聚合酶催化域功能障碍。
核心结论
- 台湾结直肠癌患者中遗传性癌症基因致病性变异占5.2%,早发性病例更高达8.2%。
- 研究识别了CCDC18、CEP135等新候选基因及POLD1新发终止变异p.Y594X,支持扩展亚洲变异数据库以改善风险评估。
研究设计与样本
- 对600例台湾结直肠癌患者行全外显子测序,按ACMG指南评估变异致病性,并与1492例对照进行对比分析。
主要发现
- 5.2%的患者携带遗传性癌症基因致病性变异,早发性病例中该比例为8.2%。
- 在26岁患者中检出POLD1新发终止变异p.Y594X,提示聚合酶催化域功能障碍。
- ATM相关风险为1.3%,并关注MUTYH变异c.850-2A>G。
- 25.5%的罕见风险变异为新发现,41个候选致病性变异与家族及早发性结直肠癌相关。
- 识别出CCDC18和CEP135等新候选基因。
临床怎么用
- 对早发性及有家族史的结直肠癌患者应考虑胚系基因检测,以识别遗传性癌症综合征。
- 检测结果可辅助制定个体化筛查与管理策略,并提示需扩展亚洲人群变异数据库。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Germline genetic factors influence the clinical features of colorectal cancer (CRC); however, these factors remain underexplored in Taiwan. This study aims to evaluate the pathogenicity of germline variants and investigate their associations with familial risk and early-onset CRC. METHODS: Whole exome sequencing of 600 Taiwanese patients with CRC was analyzed, assessing variant pathogenicity using American College of Medical Genetics and Genomics (ACMG) guidelines. Comparative analysis with 1492 controls identified candidate genes, and clinical features were correlated with genetic variants. RESULTS: We identified several novel candidate genes, including CCDC18 and CEP135. A total of 24 pathogenic variants in hereditary cancer genes were found in 5.2% of Taiwanese patients with CRC, with the highest prevalence observed in early-onset cases (8.2%). Notably, a novel stop-gain variant in POLD1 (p.Y594X) was detected in a 26-year-old patient, suggesting dysfunction of the polymerase catalytic domain. The risks associated with ATM (1.3%) and the MUTYH (c.850-2A>G) variant were also highlighted. Additionally, 25.5% of rare-risk variants were novel, with 41 candidate pathogenic variants linked to familial and early-onset CRC. CONCLUSIONS: These findings improve our understanding of germline genetics in Taiwanese CRC, support better screening and management strategies, and highlight the need to expand Asian variant databases for improved risk assessment and care.
引用
- Huang YC, Chen YN, Chung AK, et al. Whole Exome Sequencing-identified Germline Variants Underlie High Familial Risk and Early-onset Colorectal Cancer in Taiwan. Clin Gastroenterol Hepatol. 2025. PMID: 40780402. doi:10.1016/j.cgh.2025.07.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。